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Objectives: This study assesses the impact of the English National Health Service (NHS)
Health Technology Assessment (HTA) program using the “payback”
framework.
Methods: A survey of lead investigators of all research projects funded by the HTA
program 1993–2003 supplemented by more detailed case studies of sixteen
projects.
Results: Of 204 eligible projects, replies were received from 133 or 65 percent. The mean
number of peer-reviewed publications per project was 2.9. Seventy-three percent of
projects claimed to have had had an impact on policy and 42 percent on behavior.
Technology Assessment Reports for the National Institute for Health and Clinical
Excellence (NICE) had fewer than average publications but greater impact on policy. Half
of all projects went on to secure further funding. The case studies confirmed the survey
findings and indicated factors associated with impact.
Conclusions: The HTA program performed relatively well in terms of “payback.”
Facilitating factors included the program’s emphasis on topics that matter to the NHS,
rigorous methods and the existence of “policy customers” such as NICE.
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Given the considerable investment in health-related research
assessing its impact could help increase accountability,
help identify ways to maximize impact and justify fund-
ing (1;4).Questions about these issues are increasingly being
asked in the United Kingdom and internationally.
A comprehensive review of studies of the impact from
health research programs was linked to the work reported
here (8). Several studies examined the payback from diverse
research programs (as opposed to individual projects), gener-
ally indicating a higher level of impact than is often thought to
exist. Examples covered some health technology assessment
programs such as in Quebec (12;13) and other programs that
were broader in scope, including from the United Kingdom
(7), the United States (21), and Australia (20). Since that
review was completed, further studies have revealed consid-
erable levels of impact (14;17;19).
The review (8) confirmed that the “payback” framework
pioneered by Buxton and Hanney (4) was the most commonly
used approach to assess the impact from health research. This
framework consists of a multi-dimensional categorization of
benefits (including the contribution to knowledge and influ-
ence on policy, practice and health gain), and a model of how
best to assess these impacts (10). The present study describes
the application of the payback framework to the largest pro-
gram within NHS R&D, the Health Technology Assessment
(HTA) program. The full report (8) describes the background
to the program, including unique features such as the HTA
monograph series, and includes the research protocol.
The aim of the project was to assess the “payback”
from the HTA program. We report the results of a survey of
204 principal investigators (PIs) who had completed projects
funded by the HTA program in its first 10 years between
1993 and 2003 supplemented by more detailed case studies
of sixteen research projects).
METHODS
The eligible population comprised researchers who had been
funded by the HTA Program and had submitted a final draft
report between the beginning of the Program in 1993 and
30 June 2003. The National Coordinating Centre for HTA
(NCCHTA), which manages the HTA program, provided a
full list of projects. Methodology Reviews were excluded as
these constituted a separate program from 2000. Projects that
had been discontinued, or which had not required a publi-
cation were also excluded as these are considered elsewhere
(the former under “failure” rate, the latter under feasibil-
ity studies) (8). Of the 258 projects potentially eligible, 38
were excluded as methodology, 10 as “discontinued,” and 6
more as “no publication was required.” Some projects that
had completed but whose reports had not been accepted by
NCCHTA were included. These exclusions reduced the sam-
pling frame to 204.
The survey was organized around the “payback” frame-
work which required data on: publications, presentations,
further linked research, and impact on policy and behavior
(4). Policy impact was broadly defined covering both na-
tional and local. A questionnaire previously used by Hanney
et al. (11) was piloted and slightly amended. The survey
was carried out in mid-2005. Questionnaires were mailed
to all eligible researchers with follow up reminders by mail
and email. Where researchers were reported to have moved,
questionnaires were sent to current addresses.
Three types of project were distinguished: (a) primary
research mainly randomized controlled trials; (b) secondary
research, including systematic reviews, meta-analysis and
modeling of cost effectiveness, and (c) Technology Assess-
ment Reports (TARs) for NICE.
Sixteen case studies provided more detail of impact, on
the factors associated with it and on the best way to assess it.
Nine primary studies, four secondary, and three NICE TARs
were selected to be case studies on the basis of stratified
random selection (8) from the 204 projects, the first time to
our knowledge that case studies have been randomly selected.
The case studies consisted of interviews with princi-
pal investigators, analysis of documents referred to by the
principal investigators, analysis of key citations to the main
papers, and review studies of the impact of NICE. The case
studies were written up using all the data available, organized
according to the stages of the Payback framework.
RESULTS
A total of 133 replies were received or 65 percent, with a
slightly higher response rate for the NICE TARs at 74 per-
cent. Analysis of NCCHTA routine data showed that nonre-
sponders tended to have fewer peer-reviewed publications,
fewer Web “hits” (NCCHTA maintains data on the number
of internet connections made to each published report), and
to be from the earlier years of the program (8).
Publications
The total number of publications was 574, with peer reviewed
journal articles at 263 constituting 45 percent of the total. The
only other large group was published presentations at 240,
with the most significant of the remaining publications being
eight editorials, four books and two book chapters.
The mean number of peer reviewed publications was
2.93 per project including the HTA Program monographs.
Higher ratios applied to primary research (3.82) and sec-
ondary research (3.36) compared with TARs (1.81). Exclud-
ing the HTA Program monographs would reduce these values
by close to one because almost all projects lead to a mono-
graph.
A total of 5.2 presentations were made per project. Most
(55 percent) were to academic audiences, followed by those
to practitioners with relatively few to service users.
Almost half (46 percent) went on to receive further fund-
ing. This was more likely for primary and secondary research
than for the technology assessments for NICE.
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Table 1. Opinion of Lead Researchers about Existing and Potential Impact on Policy and Behavior
Policy Behavior
Already Future Combineda Already Future Combineda
(%) (%) (%) (%) (%) (%)
Primary research 25 (66) 27 (71) 29 (76) 17 (45) 21 (55) 23 (61)
Secondary research 27 (57) 27 (57) 36 (77) 10 (21) 22 (47) 25 (53)
NICE TARs 46 (96) 29 (60) 48 (100) 29 (60) 28 (58) 37 (77)
98 (73%) 83 (62%) 113 (85%) 56 (42%) 70 (53%) 85 (64%)
aCombined indicates number in “already” + number with no entry under “already” claiming a future impact.
Respondents were asked to indicate if, in their view,
their project had impacted on policy or behavior. Approxi-
mately three quarters of the respondents claimed that their
project had impacted on policy and just over half on behavior
(Table 1). Similar figures applied to expected future impact,
slightly lower compared to the past for policy and slightly
higher for behavior. When past and future impacts were com-
bined (excluding double counting) 85 percent of projects
claimed an impact on policy and 64 percent on behavior. The
totals were higher for NICE TARs with 96 percent claiming
to have impacted on policy, as might be expected given their
role.
The timeliness and quality of the research, and liaison
with stakeholders, were factors which respondents linked to
the impact of their work. Some referred to the importance
of having a clear policy “customer” such as NICE or the
National Screening Committee. Some who had led system-
atic reviews emphasized the importance of their study in
identifying the need for further research such as randomized
controlled trials.
The most common reason for lack of impact was timing.
Some thought it too soon for the report to have had impact.
Some critical comments were made about the slowness of
aspects of the HTA process. Two respondents referred to dif-
ficulties arising from their findings being contrary to current
government policy. Two others referred to the problems of
negative findings. The extent to which these perceptions are
well founded has not been addressed.
Case Studies
The case studies indicated the range of policies that have been
informed (e.g., NICE guidance and guidelines; decisions by
the National Screening Committee; National Service Frame-
works; guidelines from the Scottish Intercollegiate Guide-
lines Network and many other national and international
bodies).
Eleven of the sixteen case studies claimed to have made
some impact on policy at the level of a national professional
body or policy-making body, sometimes substantially. Some
of the impact was international, including impact on guide-
lines in the United States for the treatment of stroke (6) and
of dyspepsia (2). (See Box 1.)
Even with such clear examples of impact, it was not
possible to specify the counter-factual. Some of the changes
in policy and practice might have come about because of
pressure from other sources. In some instances, however, the
evidence produced by some studies was the main reference
given to support certain policies (8), for example, a study
from the HTA-funded trial of treatments for depression in
general practice (22) was cited as the sole evidence to support
the statement in the National Service Framework for Older
People that counseling in primary care may also be effective
for depression (5).
DISCUSSION
One potential bias in this study arises from it having been
commissioned by the HTA program and carried out a team
some of whom have previous or ongoing funding from that
program. In addition to being fully acknowledged, this dan-
ger was mitigated by being supervised by an independent
Advisory Group (8). Neither the HTA Program nor NCCHTA
had any influence on the conduct of the research or its in-
terpretation. Another possible bias could arise from the use
of self-reported by the lead researchers, who might exag-
gerate the importance of their study. The case studies used
documentary analysis to check the claims made in both the
relevant surveys and interviews. The survey could also be
biased by its response rate with around one third not re-
sponding. However, given the time frame 1993–2003, loss
(death, retirement, emigration) of some lead investigators
was inevitable. Nonresponders tended to have had less suc-
cessful projects (fewer publications or web hits) and to be
from the earlier years of the program (8). A similar response
rate has applied to similar surveys (8).
There are genuine concerns about how far research can
impact on health policy (3), but the review (8) suggests that
higher levels of research impact on policy and practice can
sometimes be identified than is often thought to be the case.
In particular, impact was identified in studies that worked
forward from research projects to analyze the impact made.
Although tracing impact forward from particular studies, as
in the “payback” approach, may exaggerate their effects, this
approach does help indicate the existence of impact, which
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Box 1. Case Study 1: A randomized controlled comparison of alternative strategies in stroke care. (HTA study 93/03/26)
Stroke is the single most expensive disorder managed in general hospitals, with a burden likely to increase. Debates about how it
should best be managed in hospitals led the HTA to invite tenders to compare different approaches.
The study received £0.5 m from the HTA Program to conduct a prospective, single-blind, randomized controlled trial. Between
October 1995 and March 1998 patients were recruited from a community-based stroke register. Those with severe stroke were
excluded. The study had three arms: the stroke unit providing 24-hour care from a specialist multidisciplinary team with clear
guidelines for acute care, prevention of complications, rehabilitation and secondary prevention; the stroke team that involved
management on general wards with specialist team support to provide stroke assessments; domiciliary care consisting of
management at home under the supervision of a GP and stroke specialist with support from specialist team and community services
for a maximum of 3 months.
In their HTA monograph, the authors concluded that, “Management of stroke patients on general medical wards, even with
specialist team support, cannot be recommended because of the high mortality and dependence rate. . . .a role for specialist
domiciliary services for acute stroke was not supported. . . the stroke unit is a more cost-effective intervention than either the stroke
team or home care.” (15)
The quality of the study and its importance is indicated by publications in several major journals. Two papers were published in
the very high impact Lancet, including the main clinical paper (16) which has been cited over 60 times. Two other papers were
published in Stroke, a major specialist journal, including the cost-effectiveness paper the importance of which was highlighted in an
accompanying editorial.
The papers are cited in several systematic reviews, including some Cochrane reviews, especially the one by the Stroke Unit
Trialists’ Collaboration on Organised Inpatient (stroke unit) Care for Stroke. In this it was one of only five studies for which outcome
data were available for a comparison of different forms of organized stroke unit care. It was given the top grade for its methods.
The study seems to have had a considerable impact on policy at various levels. The National Clinical Guidelines for Stroke from
the Royal College of Physicians cite both the Kalra et al. 2000 paper directly and the Cochrane review, again noting the strength of
evidence and stressing that the recommendation that patients are admitted under the care of a specialist team for their acute care and
rehabilitation should be the highest priority. Guidelines in several countries also cite papers from this study, including one from
SIGN. The Stroke Council of the American Heart Association recently endorsed the guidelines from Veteran Affairs/Department of
Defence and these cited both Lancet articles as important evidence on the organization of stroke care (6).
The study showed various gains, especially reduced mortality, from the provision of care in specialist stroke units. It is therefore
reasonable to suggest that following the widespread adoption of stroke units there has been a health gain. There will also have been
reduced morbidity and increased patient satisfaction from the move away from care on general wards and increase provision of
specialist units. The difficulty comes in relation to the counterfactual: how far would these changes have come about without the
study. Policy and practice were probably moving in the direction indicated by the findings of this study, but it provided high quality
evidence that seems to have been influential in promoting the changes.
can then be explored in greater detail in case studies such as
those described here.
The review also highlighted the potential importance
of the context in which the program of research is con-
ducted (12;13), especially the existence of “customers” or
“receptor bodies” (9;18). The HTA program work commis-
sions work for such bodies, including NICE and the National
Screening Committee, both of which issue or recommend
policy.
Both the nature and context of the HTA Program are
unique, limiting comparison between it and other research
programs. No other HTA program provides comparable in-
put to a NICE-type decision-making agency. Few other HTA
programs include clinical trials. Other unique characteris-
tics include the program’s emphasis on funding scientific
research on topics that matter to the NHS. Its success with
publications may reflect the programs emphasis on rigorous
science, which is often path-breaking in relation to the topics
selected. The specified use of rigorous methods (systematic
reviews, meta-analysis, randomized controlled clinical trials)
to a large degree ensured high quality research, particularly
when coupled with rigorous peer review.
The survey revealed dissatisfaction with some aspects of
the program, particularly in the length of time taken to agree
funding and to publish the monographs. Some researchers
considered that these delays reduced the impact of the re-
search.
CONCLUSIONS
Overall, the HTA Program has had considerable impact as
measured by the “payback” approach. The number of peer
reviewed publications per project compared well with other
programs. Similarly, the impact on policy and behavior was
considerable, particularly when clear policy “customers” ex-
isted.
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